IP Library Granted Patent US 8,620,405
Granted Patent B2
US 8,620,405 · App. 13/318,806 · Granted Dec 31, 2013

Skin marker

Inventors: Brian McClelland (County Antrim, GB); Robert John Winder (Northern Ireland, GB); Justin Dominic Martin Magee (County Londonderry, GB); Paul McCarron (County Down, GB)
Assignee: University of Ulster
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,620,405
App. No.
13/318,806
Granted
Dec 31, 2013
Kind
B2
Abstract

A skin marker for providing a reference point for a plurality of different medical imaging procedures, said marker incorporating one or more substances having one or more of radiance and/or hydration and/or radiopaque and/or radio luminescent and/or radioactive properties for detection by X-ray and/or Computer Tomography (CT) and/or MRI and/or Ultrasonic scanning processes and/or Positron Emission Tomography (PET), and one or more markings recognizable by an optical imaging process such as 3D surface scanning.

Claims (24)

1. A skin marker for providing a reference point for a plurality of different medical imaging procedures, said marker comprising:

at least one substance having one or more properties chosen from (i) radiance, (ii) hydration, (iii) radiopaqueness, (iv) radio luminescence, and (v) radioactivity, for detection by one or more of (i) X-ray, (ii) Computer Tomography (CT), (iii) MRI, (iv) Ultrasonic scanning processes, and (v) Positron Emission Tomography (PET);

at least one first marking comprising a substantially non-reflective marking that is recognisable by Moiré Fringe 3D scanning processes; and

at least one second marking comprising a coloured marking recognizable by a colour recognition imaging process;

wherein said at least one first marking is distinguishable from said at least one second marking by the Moiré Fringe 3D scanning processes, and wherein said at least one second marking is distinguishable from said at least one first marking by the colour recognition imaging process.

2. A skin marker as claimed in claim 1 , wherein said at least one substance comprises a radiopaque material having a radiographic density sufficient to produce a discernable pattern on a radiographic image.

3. A skin marker as claimed in claim 1 , wherein the marker includes a 3D surface formation.

4. A skin marker as claimed in claim 3 , wherein said at least one substance is encapsulated within said 3D surface formation.

5. A skin marker as claimed in claim 3 , wherein said 3D surface formation comprises a dome shaped member defining a substantially hemi-spherical surface formation.

6. A skin marker as claimed in claim 5 , wherein said dome shaped member is located on a central portion of the marker.

7. A skin marker as claimed in claim 5 , wherein at least a portion of the dome shaped member comprises an optically transparent magnifying lens to assist correct location of the marker on a skin surface.

8. A skin marker as claimed in claim 3 , wherein the 3D surface formation is coloured and is provided with markings to provide enhanced visibility.

9. A skin marker as claimed in claim 3 , wherein said 3D surface formation comprises a hollow body for containing said at least one substance, and wherein said at least one substance comprises a liquid, a semi-liquid or a solid material.

10. A skin marker as claimed in claim 9 , wherein said material comprises one or more of (i) an oil based liquid, (ii) an oil-based semi-solid material, or (iii) a gelled material.

11. A skin marker as claimed in claim 10 , wherein said material comprises said gelled material, said gelled material comprising an oil or aqueous base having a rheological structure, achieved by way of (i) high polymeric concentration, (ii) incorporation of stiffening agents, (iii) induced hydrogen bonding, or (iv) covalent cross-linking using molecular or ionic species.

12. A skin marker as claimed in claim 3 , wherein said at least one marking comprises one or more concentric rings or ring-like markings located around said 3D surface formation.

13. A skin marker as claimed in claim 1 , wherein the skin marker further comprises two or more tabs or wings to enable the marker to be attached to a person's body.

14. A skin marker as claimed in claim 13 , wherein said tabs or wings extend radially from a central portion of the marker.

15. A skin marker as claimed in claim 13 , wherein said tabs or wings are provided with a suitable adhesive to enable the marker to be affixed to a skin surface.

16. A skin marker as claimed in claim 15 , wherein said adhesive is covered by a releasable cover material.

17. A skin marker as claimed in claim 13 , wherein said tabs or wings define locations or carriers for the attachment of surgical tape to enable the marker to be affixed to a skin surface.

18. A skin marker as claimed in claim 13 , wherein each of said tabs or wings comprises an indent or reduced width region at a neck of said tab or wing to increase flexion of said tab or wing.

19. A skin marker as claimed in claim 1 , wherein said first marking comprises a matt black printed marking.

20. A skin marker as claimed in claim 1 , wherein said second marking comprises a blue or green marking.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2011
From: MCCLELLAND, BRIAN; WINDER, ROBERT JOHN; MAGEE, JUSTIN DOMINIC MARTIN; MCCARRON, PAUL
To: UNIVERSITY OF ULSTER
Reel/Frame 027174/0613 →
Priority Claims (2)
GB 0907874.2 · May 8, 2009 · national
GB 0916099.5 · Sep 14, 2009 · national
Continuity (1)
Related Publication 20120059244A1 · Mar 8, 2012